SUPPORTING STEMM DIVERSITY AND INCLUSION INITIATIVES FOR WOMEN IN ARTHROPLASTY, SURGERY AND ORTHOPAEDIC ONCOLOGY
With
Associate Professor Claudia Di Bella
Orthopaedic surgeon, Melbourne &
Associate Professor of Surgery
University of Melbourne
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Sydney | June 2026
Associate Professor Claudia Di Bella is an academic orthopaedic surgeon based in Melbourne, specialising in orthopaedic oncology and complex joint reconstruction. Originally trained at the world-renowned Rizzoli Orthopaedic Institute (Istituto Ortopedico Rizzoli) in Bologna, Italy, she moved to Australia in 2010 and was awarded Fellowship of the Royal Australasian College of Surgeons in 2013.
She is Associate Professor of Surgery at the University of Melbourne and leads a translational research program focused on tissue engineering and innovative solutions to improve outcomes for patients with musculoskeletal disease, in particular bone sarcomas. Her research has attracted over AUD $6 million in competitive funding, including an NHMRC–MRFF Clinical Investigator Grant, and has resulted in more than 60 peer-reviewed publications, book chapters and numerous national and international presentations. She is passionate about bridging the gap between scientific discovery and meaningful improvements in patient care.
Clinically, A/Prof Di Bella is one of Australia’s few orthopaedic oncology surgeons, managing complex bone and soft tissue tumours and performing high-volume limb salvage surgery and joint reconstruction. Her work combines surgical expertise, innovation and multidisciplinary care for patients facing life-changing diagnoses.
Beyond her clinical and academic roles, Claudia is a strong advocate for diversity, inclusion and representation in medicine. Through national and international leadership roles, including within orthopaedic surgery and sarcoma organisations, she actively mentors the next generation of surgeons and researchers, with a particular commitment to supporting women and underrepresented groups in STEMM and surgical careers.
Source: Supplied
Media access credit: Medical Technology Association of Australia (MTAA)
You Might also like
-
Cardiovascular Disease Risk Guidance and Calculator get long overdue update
Cardiovascular disease (CVD) is responsible for significant morbidity and premature mortality in Australia. Ischaemic heart disease was the leading cause of death in 2020 and cerebrovascular disease was the third most common cause of death.
As the first major update to Australian CVD risk assessment guidelines in over a decade, the 2023 Australian Guideline for assessing and managing cardiovascular disease risk and associated Aus CVD Risk Calculator reflect the latest evidence on assessing, communicating, and managing CVD risk. Developed using Australian-specific data and the latest evidence, it supersedes the 2012 Guidelines for the management of absolute cardiovascular disease risk.
-
Breaking silos to transform women’s health through MedTech
In an interview with Australian Health Journal, Jasjit Baveja, Director of Regulatory and Industry Policy at the Medical Technology Association of Australia (MTAA), highlighted the growing importance of medical technology in addressing longstanding inequities in women’s health.
Drawing on the outcomes of the inaugural MTAA Women’s Health MedTech Summit, she explained how the event brought together clinicians, researchers, industry leaders, regulators, investors, government representatives and patient advocates to tackle complex challenges through a collaborative approach.
-
Role of the Chief Nursing Officer
Professor Alison McMillan PSM spoke with Australian Health Journal about the role of Chief Nursing and Midwifery Officer at the Australian Government Department of Health and Aged Care.
Alison was appointed as our Chief Nursing and Midwifery Officer in November 2019.
In June 2021 Alison was awarded a Public Service Medal for outstanding public service to driving the Government’s national health response priorities during the COVID-19 pandemic, particularly to infection prevention measures.